| Titre : |
Pharmacogenomics : A Primer for Clinicians |
| Type de document : |
texte imprimé |
| Auteurs : |
Lam Jerika T., Auteur ; Mary A. Gutierrez, Auteur |
| Editeur : |
New York : McGraw-Hill |
| Année de publication : |
2021 |
| Importance : |
173p. |
| Présentation : |
ill. en coul. |
| Format : |
28x 22cm. |
| ISBN/ISSN/EAN : |
978-1-260-45711-7 |
| Langues : |
Anglais (eng) |
| Mots-clés : |
Pharmacogenomics |
| Index. décimale : |
615.35-38.1 |
| Résumé : |
An invaluable resource to the rapidly emerging field of
pharmacogenomics—complete with case studies, clinical pearls, and treatment
recommendations
The aim of pharmacogenomics is to improve personalized medicine by taking
into account how genes affect an individual’s tolerability and response to
drugs. Approaching pharmacogenomics from the current clinical, scientific,
and implementation perspectives, this guide serves as an invaluable
evidence-based resource to the subject. Reflecting the shift from genetics
to genomics in the pharmaceutical sphere, the book covers pharmacogenomics
fundamentals; genotyping tests and evidence; clinical implementation;
ethical, legal, and social issues; and more. You’ll also find illuminating
case scenarios, clinical pearls, and evidence-based recommendations for
treatments and alternatives based on CPIC, PharmGKB, and FDA guidelines.
|
| Note de contenu : |
figures;index |
Pharmacogenomics : A Primer for Clinicians [texte imprimé] / Lam Jerika T., Auteur ; Mary A. Gutierrez, Auteur . - New York : McGraw-Hill, 2021 . - 173p. : ill. en coul. ; 28x 22cm. ISBN : 978-1-260-45711-7 Langues : Anglais ( eng)
| Mots-clés : |
Pharmacogenomics |
| Index. décimale : |
615.35-38.1 |
| Résumé : |
An invaluable resource to the rapidly emerging field of
pharmacogenomics—complete with case studies, clinical pearls, and treatment
recommendations
The aim of pharmacogenomics is to improve personalized medicine by taking
into account how genes affect an individual’s tolerability and response to
drugs. Approaching pharmacogenomics from the current clinical, scientific,
and implementation perspectives, this guide serves as an invaluable
evidence-based resource to the subject. Reflecting the shift from genetics
to genomics in the pharmaceutical sphere, the book covers pharmacogenomics
fundamentals; genotyping tests and evidence; clinical implementation;
ethical, legal, and social issues; and more. You’ll also find illuminating
case scenarios, clinical pearls, and evidence-based recommendations for
treatments and alternatives based on CPIC, PharmGKB, and FDA guidelines.
|
| Note de contenu : |
figures;index |
|  |
Affiner la recherche Interroger des sources externes
